• Events Calendar
Patients Rising Now
  • Home
  • About
    • About Us
    • Partners and Coalitions
    • Corporate Membership
    • Corporate Members
  • Issues
    • Terry’s Hot Take
    • News and Insights
    • Positions
    • Policy Supported
  • Get Involved
  • Become a Member
  • Donate
Select Page
  • Home
  • About
    • About Us
    • Partners and Coalitions
    • Corporate Membership
    • Corporate Members
  • Issues
    • Terry’s Hot Take
    • News and Insights
    • Positions
    • Policy Supported
  • Get Involved
  • Become a Member
  • Donate

A dangerous plan for rationing essential prescription drugs

Aug 6, 2019 | ICER, News, QALY

The midterms are over and it’s time to get back to discussing issues that impact Americans on a daily basis. Things like health care and, specifically how to reduce costs. President Trump has made lowering the cost of prescription drugs one of his priorities. It seems...
Read more

HHS Secretary Alex Azar doesn’t want drug access to become an equation

Apr 19, 2019 | News, QALY

On April 8, at a Harvard Medical School forum hosted by Pioneer Institute, President Trump’s secretary of health and human services was asked whether it was advisable for state Medicaid programs to use “cost-effectiveness reviews” that have become common in Europe....
Read more

Categories

  • Access
  • Actions
  • Copay Accumulators
  • Copay Assistance
  • COVID-19
  • Drug Costs
  • FDA
  • Featured
  • Federal Issues
  • Health Insurance
  • Health Policy
  • ICER
  • Issues
  • Letters Submitted
  • Letters Supported
  • Massachusetts
  • Medicaid
  • Medicare
  • Medicare Part D
  • News
  • Op-Ed
  • Out of Pocket Costs
  • Pharmacy Benefit Managers
  • Podcast
  • Prescription Drugs
  • Press Releases
  • Public Statement
  • QALY
  • State Issues
  • Statements
  • Step Therapy
  • Terry's Hot Take
  • Uncategorized
  • Value Based Insurance Design
  • Value Frameworks
  • Virtual Advocacy Chat

Tags

340B Access to Care Advocacy Alzheimer's Asthma Biden Administration Cancer cms Copay Accumulators copay assistance COVID-19 Vaccine drug costs Drug Importation Drug Manufacturing Drug Pricing drug rebate fail first FDA H.R.3 Healthcare Inequities Health Insurance hospital bills HR 3708 hsa ICER Imported Drugs Insurance design Joe Biden Lupus medicare Part B medicare part D Mental Health Nonmedical Switching open enrollment Out of Pocket Costs PBM pharmacy benefit managers Price Transparency Prior Authorization QALY Rare Disease Step Therapy Telehealth transparency Value Framework

Recent Posts

  • S2 | E42: The False Promise of Current Drug Pricing Reforms
  • Coverage for Preventive Care Is a High-Value Insurance Design
  • Letter Supporting S.4111 Breslin/A.4668 Peoples-Stokes Prohibiting Non-medical Switching
  • Patients Rising Statement on Pro-Patient Health Insurance Benefit Design
  • S2 | E 41: Chronic Disease + the Next Pandemic with Scott Gottlieb

Sign up for updates


Patients Rising Now

We are a 501c4 group dedicated to demanding transparency in health care.  We are part of the Patients Rising suite of programs and services.

700 12th St. NW 700, Suite 700
Washington, DC 20005

  • Privacy Policy
  • Sponsor Opportunities
  • Patients Rising
  • Facebook
  • Twitter
  • Instagram
All rights reserved. © 2021 Patients Rising Now